Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor

Overview of attention for article published in American Journal of Pathology, September 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 12 patents

Readers on

mendeley: 42 Mendeley

So far, Altmetric has seen 12 patents that reference this research output.

Rapamycin analogs and uses thereof

Grant US-11944605-B2

United States of America

02 Apr 2024

RAPAMYCIN ANALOGS AND USES THEREOF

Application EP-4302827-A2

European Patent Office

10 Jan 2024

Rapamycin analogs and uses thereof

Grant US-11819476-B2

United States of America

21 Nov 2023

Methods of treating keloids

Grant US-11672797-B2

United States of America

13 Jun 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.